Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Yi-Wen Tsai
23733  Ergebnisse:
Personensuche X
?
1

Treatment and reuse of tunnel construction wastewater:

Yi-Wen, Tsai ; Liu, J.C. ; Sou-Sen, Leu.
Separation and Purification Technology.  84 (2012)  - p. 79-84 , 2012
Link: https://doi.org/10.1016/..
 
?
2

Efficacy of the Geriatric Nutritional Risk Index for Predic..:

Yiu, Ching-Yi ; Liu, Chien-Cheng ; Wu, Jheng-Yan...
Nutrients.  15 (2023)  20 - p. 4348 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Impact of comprehensive geriatric assessment on the risk of..:

Chuang, Min-Hsiang ; Chen, Jui-Yi ; Tsai, Wen-Wen...
Age and Ageing.  51 (2022)  7 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
4

Efficacy of methylphenidate for the treatment of apathy in ..:

Lee, Chia-Wei ; Chen, Jui-Yi ; Ko, Ching-Chung...
Psychopharmacology.  239 (2022)  12 - p. 3743-3753 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Biodiesel production from Nannochloropsis oculata cultured ..:

Zhang, Jun ; Tsai, Wen-Yi ; Hsu, Chao-Hung.
Biofuels.  13 (2020)  4 - p. 527-535 , 2020
Link: https://doi.org/10.1080/..
 
?
6

The 2017 Women's Health Initiative study and use of hormone..:

Chueh, Chen-Han ; Ho, Pei-Kuan ; Li, Wai-Hou...
BMC Public Health.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
7

Cost-effectiveness of ivosidenib versus chemotherapy for pr..:

Chen, Kuei-An ; Huang, Wei-Ming ; Chen, Eric Yi-Ting...
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
8

Cost-effectiveness analysis of atezolizumab plus bevacizuma..:

Tseng, Chien-Yu ; Tsai, Yi-Wen ; Shiu, Ming-Neng
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
9

Cost-effectiveness of pemigatinib as a second-line treatmen..:

Chen, Zi-Rong ; Chueh, Chen-Han ; Chiang, Nai-Jung.
Cost Effectiveness and Resource Allocation.  21 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
10

Image_1_Cost-effectiveness analysis of atezolizumab plus be..:

Chien-Yu Tseng ; Yi-Wen Tsai ; Ming-Neng Shiu
doi:10.3389/fonc.2023.1264417.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
11

Table_1_Cost-effectiveness analysis of atezolizumab plus be..:

Chien-Yu Tseng ; Yi-Wen Tsai ; Ming-Neng Shiu
doi:10.3389/fonc.2023.1264417.s002.  , 2023
Link: https://doi.org/10.3389/..
 
?
12

Image_1_Cost-effectiveness analysis of atezolizumab plus be..:

Chien-Yu Tseng ; Yi-Wen Tsai ; Ming-Neng Shiu
doi:10.3389/fonc.2023.1264417.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
13

Cost-effectiveness analysis of atezolizumab plus bevacizuma..:

Chien-Yu Tseng ; Yi-Wen Tsai ; Ming-Neng Shiu
https://www.frontiersin.org/articles/10.3389/fonc.2023.1264417/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
14

Table_1_Cost-effectiveness analysis of atezolizumab plus be..:

Chien-Yu Tseng ; Yi-Wen Tsai ; Ming-Neng Shiu
doi:10.3389/fonc.2023.1264417.s002.  , 2023
Link: https://doi.org/10.3389/..
 
?
15

Cost-effectiveness of pemigatinib as a second-line treatmen..:

Zi-Rong Chen ; Chen-Han Chueh ; Nai-Jung Chiang.
https://doi.org/10.1186/s12962-023-00473-5.  , 2023
Link: https://doi.org/10.1186/..
 
1-15